AI technology developer Blackford and DeepTek are partnering to make the AI-driven CXR Analyzer available on the Blackford Platform.
CXR Analyzer is a CADe software cleared by the U.S. Food and Drug Administration, Blackford noted. The tool analyzes the entire lung, pleura, and cardiac regions, using AI to identify suspicious areas. The software integrates with existing PACS, operating in the background (either on-premise or cloud-based) without interrupting current workflows, the company said.
The Blackford Platform now houses a portfolio of over 140 AI-driven solutions.
